Literature DB >> 26529075

Non-thermal plasma for inactivated-vaccine preparation.

Guomin Wang1, Ruihao Zhu2, Licong Yang2, Kaile Wang1, Qian Zhang1, Xia Su2, Bing Yang3, Jue Zhang4, Jing Fang5.   

Abstract

Vaccines are of great importance in controlling the spread of infectious diseases in poultry farming. The safety and efficacy of vaccines are also essential. To explore the feasibility of a novel technology (non-thermal plasma) in inactivated vaccine preparation, an alternating current atmospheric pressure non-thermal plasma (NTP) jet with Ar/O2/N2 as the operating gas was used to inactivate a Newcastle disease virus (NDV, LaSota) strain and H9N2 avian influenza virus (AIV, A/Chicken/Hebei/WD/98) for vaccine preparation. The results showed that complete inactivation could be achieved with 2 min of NTP treatment for both NDV and AIV. Moreover, a proper NTP treatment time is needed for inactivation of a virus without destruction of the antigenic determinants. Compared to traditional formaldehyde-inactivated vaccine, the vaccine made from NDV treated by NTP for 2 min (NTP-2 min-NDV-vaccine) could induce a higher NDV-specific antibody titer in specific pathogen-free (SPF) chickens, and the results of a chicken challenge experiment showed that NTP-2 min-NDV-vaccine could protect SPF chickens from a lethal NDV challenge. Vaccines made from AIV treated by NTP for 2 min (NTP-2 min-AIV-vaccine) also showed a similar AIV-specific antibody titer compared with traditional AIV vaccines prepared using formaldehyde inactivation. Studies of the morphological changes of the virus, chemical analysis of NDV allantoic fluid and optical emission spectrum analysis of NTP suggested that reactive oxygen species and reactive nitrogen species produced by NTP played an important role in the virus inactivation process. All of these results demonstrated that it could be feasible to use non-thermal NTP as an alternative strategy to prepare inactivated vaccines for Newcastle disease and avian influenza.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Avian influenza virus; Inactivated vaccine preparation; Newcastle disease virus; Non-thermal plasma

Mesh:

Substances:

Year:  2015        PMID: 26529075     DOI: 10.1016/j.vaccine.2015.10.099

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.

Authors:  Jing Zhao; Huiming Yang; Hongjun Xu; Zengbin Ma; Guozhong Zhang
Journal:  Virol J       Date:  2017-03-16       Impact factor: 4.099

2.  Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy.

Authors:  Zhou Hongzhuan; Tian Ying; Su Xia; Guo Jinsong; Zhang Zhenhua; Jiang Beiyu; Chang Yanyan; Lin Lulu; Zhang Jue; Yang Bing; Fang Jing
Journal:  Appl Microbiol Biotechnol       Date:  2019-11-16       Impact factor: 4.813

3.  Cellular protein GLTSCR2: A valuable target for the development of broad-spectrum antivirals.

Authors:  Cui-Cui Li; Hui-Jun Dong; Peng Wang; Wen Meng; Xiao-Jing Chi; Shi-Chong Han; Shuo Ning; Chuang Wang; Xiao-Jia Wang
Journal:  Antiviral Res       Date:  2017-03-07       Impact factor: 5.970

Review 4.  Nonthermal plasma as part of a novel strategy for vaccination.

Authors:  Hager Mohamed; Rita A Esposito; Michele A Kutzler; Brian Wigdahl; Fred C Krebs; Vandana Miller
Journal:  Plasma Process Polym       Date:  2020-07-13       Impact factor: 3.877

Review 5.  Applications and challenges of low temperature plasma in pharmaceutical field.

Authors:  Lingge Gao; Xingmin Shi; Xili Wu
Journal:  J Pharm Anal       Date:  2020-05-11

Review 6.  Review on inactivation of airborne viruses using non-thermal plasma technologies: from MS2 to coronavirus.

Authors:  Imen Assadi; Ahlem Guesmi; Oussama Baaloudj; Hichem Zeghioud; Walid Elfalleh; Naoufel Benhammadi; Lotfi Khezami; Aymen Amine Assadi
Journal:  Environ Sci Pollut Res Int       Date:  2021-11-18       Impact factor: 5.190

Review 7.  State of the art in nonthermal plasma processing for biomedical applications: Can it help fight viral pandemics like COVID-19?

Authors:  Nilanjal Misra; Sudhir Bhatt; Farzaneh Arefi-Khonsari; Virendra Kumar
Journal:  Plasma Process Polym       Date:  2021-05-13       Impact factor: 3.877

8.  Inactivation Efficacy of Nonthermal Plasma-Activated Solutions against Newcastle Disease Virus.

Authors:  Xia Su; Ying Tian; Hongzhuan Zhou; Yinglong Li; Zhenhua Zhang; Beiyu Jiang; Bing Yang; Jue Zhang; Jing Fang
Journal:  Appl Environ Microbiol       Date:  2018-04-16       Impact factor: 4.792

9.  The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo.

Authors:  Hui-Jun Dong; Zhao-Hua Wang; Wen Meng; Cui-Cui Li; Yan-Xin Hu; Lei Zhou; Xiao-Jia Wang
Journal:  Viruses       Date:  2018-11-01       Impact factor: 5.048

Review 10.  Cold Plasma, a New Hope in the Field of Virus Inactivation.

Authors:  Arijana Filipić; Ion Gutierrez-Aguirre; Gregor Primc; Miran Mozetič; David Dobnik
Journal:  Trends Biotechnol       Date:  2020-04-17       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.